Groups seek Supreme Court ruling on stem cell patent
This article was originally published in Scrip
Executive Summary
Two nonprofit organizations want the US Supreme Court to overturn a lower court's ruling involving a patent on human embryonic stem cells (hESCs) in a case being watched closely by the biopharmaceutical industry.